Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

New methods like nanoparticles and microneedles show promise for better skin drug delivery, especially for hair disorders.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Breast cancer patients should balance treatment with safe wellness practices to improve quality of life, consulting their oncologist first.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Effective diagnosis and treatment of parasitic dermatitis in dogs require systematic approaches using specific drugs and preventive measures.

Thyroid disorders significantly affect the well-being of married, urban, non-working individuals in South India.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

New drug uses show promise but need more research.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Emulgel improves skin delivery of various drugs better than traditional methods.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Most men stopped using finasteride for baldness due to unsatisfactory results or were lost to follow-up, and those who continued saw minimal to moderate improvement.

Leflunomide is more likely to help treat alopecia areata than cause it.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Finasteride effectively treats male pattern baldness, improving hair growth and density.